POSITION：HOME > Pharmaceutical Catalogue > Axitinib > Axitinib Drug News
Axitinib
Axitinib

Axitinib (Inlyta,Asidx)

Axitinib is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma (RCC) following failure of prior systemic therapy.

  • 5mg*30tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.
Authentic
Guarantee
Fast Delivery
Privacy